http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0174395-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_700ff9a01db2075489cb7ed87392dc28
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-343
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
filingDate 2001-03-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2a9460d0704675cc580908cd9dd9bfdb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_be327eee0c3f20e4fd4585689325b214
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d43839f96722b3a8a86d8d2ead8cd3e1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7f3bdf7fd8976737ee91b6b14badbb13
publicationDate 2002-02-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-0174395-A3
titleOfInvention Amiodarone-containing parenteral solution
abstract The present invention provides an amiodarone parenteral solution suitable for intravenous administration without the necessity of dilution. The parenteral solution has an amiodarone concentration from 0.2 to 10 mg/ml and a buffer solution selected from the group consisting of lactate buffer, methanesulfonate buffer, or combinations thereof, the solution having a pH within the range from approximately 2.5 - 4.5.
priorityDate 2000-03-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6030998-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5234949-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453034310
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419533141
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID409982726
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2157
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419474469
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID85257
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406483
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID91435
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID516892

Total number of triples: 38.